Eplerenone for chronic central serous chorioretinopathy - Authors' reply.
Saved in:
| Title: | Eplerenone for chronic central serous chorioretinopathy - Authors' reply. |
|---|---|
| Authors: | Lotery A; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK. Electronic address: a.j.lotery@soton.ac.uk., O'Connell A; Bristol Trials Centre, Clinical Trials and Evaluation Unit, Bristol Medical School, University of Bristol, Bristol Royal Infirmary, Bristol, UK., Harris RA; Bristol Trials Centre, Clinical Trials and Evaluation Unit, Bristol Medical School, University of Bristol, Bristol Royal Infirmary, Bristol, UK., Sivaprasad S; NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital National Health Service Foundation Trust, London, UK., Reeves BC; Bristol Trials Centre, Clinical Trials and Evaluation Unit, Bristol Medical School, University of Bristol, Bristol Royal Infirmary, Bristol, UK. |
| Source: | Lancet (London, England) [Lancet] 2020 Nov 14; Vol. 396 (10262), pp. 1557-1558. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
